Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study

Linda GjØra, BjØrn Heine Strand, Sverre Bergh, Tom Borza, Anne Brækhus, Knut Engedal, Aud Johannessen, Marte Kvello-Alme, Steinar Krokstad, Gill Livingston, Fiona E Matthews, Christian Myrstad, Håvard Skjellegrind, Pernille Thingstad, Eivind Aakhus, Stina Aam, Geir Selbæk, Linda GjØra, BjØrn Heine Strand, Sverre Bergh, Tom Borza, Anne Brækhus, Knut Engedal, Aud Johannessen, Marte Kvello-Alme, Steinar Krokstad, Gill Livingston, Fiona E Matthews, Christian Myrstad, Håvard Skjellegrind, Pernille Thingstad, Eivind Aakhus, Stina Aam, Geir Selbæk

Abstract

Background: Having accurate, up-to-date information on the epidemiology of mild cognitive impairment (MCI) and dementia is imperative.

Objective: To determine the prevalence of MCI and dementia in Norway using data from a large population-based study.

Methods: All people 70 + years of age, n = 19,403, in the fourth wave of the Trøndelag Health Study (HUNT4) were invited to participate in the study HUNT4 70 + . Trained health personnel assessed participants using cognitive tests at a field station, at homes, or at their nursing home. Interviewers also completed a structured carer questionnaire in regard to participants suspected of having dementia. Clinical experts made diagnoses according to DSM-5 criteria. We calculated prevalence weighing the data to ensure population representativeness.

Results: A total of 9,930 (51.2%) of the possible 19,403 people participated, and 9,663 of these had sufficient information for analysis. Standardized prevalence of dementia and MCI was 14.6% (95% confidence interval (CI) 13.9-15.4) and 35.3% (95% CI 34.3-36.4), respectively. Dementia was more prevalent in women and MCI more prevalent in men. The most prevalent dementia subtype was Alzheimer's disease (57%). By adding data collected from a study of persons < 70 years in the same region, we estimate that there are 101,118 persons with dementia in Norway in 2020, and this is projected to increase to 236,789 and 380,134 in 2050 and 2100, respectively.

Conclusion: We found a higher prevalence of dementia and MCI than most previous studies. The present prevalence and future projections are vital for preparing for future challenges to the healthcare system and the entire society.

Keywords: Alzheimer’s disease; dementia; epidemiology; population study; prevalence.

Conflict of interest statement

Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/20-1275r1).

Figures

Fig. 1
Fig. 1
Flow chart.

References

    1. World Health Organization, Alzheimer’s Disease International, (2012) Dementia: A public health priority. World Health Organization, Geneva.
    1. Prince M, Wimo A, Guerchet M, Ali GC, Wu Y-T, Prina M (2015) World Alzheimer Report. The Global Impact of Dementia An analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International, London.
    1. Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M (2016) World Alzheimer Report 2016 Improving healthcare for people with dementia. Coverage, quality and costs now and in the future. Alzheimer’s Disease International, London.
    1. World Health Organization (2017) Global action plan on the public health response to dementia 2017-2025. World Health Organization, Geneva.
    1. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A (2000) Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54, S4–9.
    1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 9, 63–75.
    1. Fiest KM, Jette N, Roberts JI, Maxwell CJ, Smith EE, Black SE, Blaikie L, Cohen A, Day L, Holroyd-Leduc J, Kirk A, Pearson D, Pringsheim T, Venegas-Torres A, Hogan DB (2016) The prevalence and incidence of dementia: A systematic review and meta-analysis. Can J Neurol Sci 43(Suppl 1), S3–S50.
    1. Alzheimer Europe (2019) Dementia in Europe Yearbook 2019. Estimating the prevalence of dementia in Europe. Alzheimer Europe, Luxembourg.
    1. Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, Brayne C, Medical Research Council Cognitive Function and Ageing Collaboration (2013) A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II. Lancet 382, 1405–1412.
    1. Wolters FJ, Chibnik LB, Waziry R, Anderson R, Berr C, Beiser A, Bis JC, Blacker D, Bos D, Brayne C, Dartigues JF, Darweesh SKL, Davis-Plourde KL, de Wolf F, Debette S, Dufouil C, Fornage M, Goudsmit J, Grasset L, Gudnason V, Hadjichrysanthou C, Helmer C, Ikram MA, Ikram MK, Joas E, Kern S, Kuller LH, Launer L, Lopez OL, Matthews FE, McRae-McKee K, Meirelles O, Mosley TH Jr., Pase MP, Psaty BM, Satizabal CL, Seshadri S, Skoog I, Stephan BCM, Wetterberg H, Wong MM, Zettergren A, Hofman A (2020) Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium. Neurology 95, e519–e531.
    1. Wu YT, Beiser AS, Breteler MMB, Fratiglioni L, Helmer C, Hendrie HC, Honda H, Ikram MA, Langa KM, Lobo A, Matthews FE, Ohara T, Peres K, Qiu C, Seshadri S, Sjolund BM, Skoog I, Brayne C (2017) The changing prevalence and incidence of dementia over time - current evidence. Nat Rev Neurol 13, 327–339.
    1. Langa KM, Larson EB, Crimmins EM, Faul JD, Levine DA, Kabeto MU, Weir DR (2017) A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012. JAMA Intern Med 177, 51–58.
    1. Winblad I, Viramo P, Remes A, Manninen M, Jokelainen J (2010) Prevalence of dementia - a rising challenge among ageing populations. Eur Geriatr Med 1, 330–333.
    1. Mathillas J, Lövheim H, Gustafson Y (2011) Increasing prevalence of dementia among very old people. Age Ageing 40, 243–249.
    1. Misiak B, Cialkowska-Kuzminska M, Frydecka D, Chladzinska-Kiejna S, Kiejna A (2013) European studies on the prevalence of dementia in the elderly: Time for a step towards a methodological consensus. Int J Geriatr Psychiatry 28, 1211–1221.
    1. Bruti G, Cavallucci E, Mancini M, Bitossi A, Baldereschi M, Sorbi S (2016) A systematic review of the quality of studies on dementia prevalence in Italy. BMC Health Serv Res 16, 615.
    1. Prince M (2003) Commentary: Two-phase surveys. A death is announced; no flowers please. Int J Epidemiol 32, 1078–1080.
    1. Brayne C, Davis D (2012) Making Alzheimer’s and dementia research fit for populations. Lancet 380, 1441–1443.
    1. Breeze E, Hart NJ, Aarsland D, Moody C, Brayne C (2015) Harnessing the power of cohort studies for dementia research. J Public Ment Health 14, 8–17.
    1. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de LM, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van DC, Visser P, Petersen RC (2004) Mild cognitive impairment–beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240–246.
    1. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183–194.
    1. Ganguli M, Snitz BE, Saxton JA, Chang CC, Lee CW, Vander Bilt J, Hughes TF, Loewenstein DA, Unverzagt FW, Petersen RC (2011) Outcomes of mild cognitive impairment by definition: A population study. Arch Neurol 68, 761–767.
    1. Sachdev PS, Lipnicki DM, Crawford J, Reppermund S, Kochan NA, Trollor JN, Wen W, Draper B, Slavin MJ, Kang K, Lux O, Mather KA, Brodaty H (2013) Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: A population-based study. PLoS One 8, e59649.
    1. Sachdev PS, Lipnicki DM, Kochan NA, Crawford JD, Thalamuthu A, Andrews G, Brayne C, Matthews FE, Stephan BC, Lipton RB, Katz MJ, Ritchie K, Carriere I, Ancelin ML, Lam LC, Wong CH, Fung AW, Guaita A, Vaccaro R, Davin A, Ganguli M, Dodge H, Hughes T, Anstey KJ, Cherbuin N, Butterworth P, Ng TP, Gao Q, Reppermund S, Brodaty H, Schupf N, Manly J, Stern Y, Lobo A, Lopez-Anton R, Santabarbara J, Cohort Studies of Memory in an International Consortium (COSMIC) (2015) The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: The COSMIC Collaboration. PLoS One 10, e0142388.
    1. Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L (2014) Mild cognitive impairment: A concept in evolution. J Intern Med 275, 214–228.
    1. Espinosa A, Alegret M, Valero S, Vinyes-Junqué G, Hernández I, Mauleón A, Rosende-Roca M, Ruiz A, López O, Tárraga L, Boada M (2013) A longitudinal follow-up of 550 mild cognitive impairment patients: Evidence for large conversion to dementia rates and detection of major risk factors involved. J Alzheimers Dis 34, 769–780.
    1. Ferman TJ, Smith GE, Kantarci K, Boeve BF, Pankratz VS, Dickson DW, Graff-Radford NR, Wszolek Z, Van Gerpen J, Uitti R, Pedraza O, Murray ME, Aakre J, Parisi J, Knopman DS, Petersen RC (2013) Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology 81, 2032–2038.
    1. Norwegian Ministry of health and Care Services (2015) Dementia Plan 2020, A More Dementia-friendly Society.
    1. NTNU - HUNT Research Centre, The HUNT Study - a longitudinal population health study in Norway, NTNU, , Accessed August 17, 2020.
    1. Krokstad S, Langhammer A, Hveem K, Holmen TL, Midthjell K, Stene TR, Bratberg G, Heggland J, Holmen J (2013) Cohort profile: The HUNT Study, Norway. Int J Epidemiol 42, 968–977.
    1. Nordog SØr-TrØndelag County County, TrØndelag i tall 2016 – Statistikk og fakta om TrØndelag [TrØndelag in numbers 2016 – Statistics and facts on TrØndelag] , Accessed February 20, 2020.
    1. Dietrichson S, Nordmenns helse under lupen [Norwegian people’s health closely investigated], Dece-mber 16, 2019, Accessed January 17, 2020.
    1. Kvello-Alme M, Brathen G, White LR, Sando SB (2019) The prevalence and subtypes of young onset dementia in central Norway: A population-based study. J Alzheimers Dis 69, 479–487.
    1. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695–699.
    1. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C (1989) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 39, 1159–1165.
    1. Schmitt FA, Saxton J, Ferris SH, Mackell J, Sun Y (2013) Evaluation of an 8-item Severe Impairment Battery (SIB-8) vs. the full SIB in moderate to severe Alzheimer’s disease patients participating in a donepezil study. Int J Clin Pract 67, 1050–1056.
    1. Saxton J, Gonigle-Gibson K, Swihart A, Miller V, Boller F (1990) Assessment of the severely impaired patient: Description and validation of a new neuropsychological test battery. Psychol Assess 2, 298–303.
    1. American Psychiatric Association (2013) Diagnostic and statistic manual of mental disorders: DSM-5, American Psychiatric Association, Washington DC.
    1. Borland E, Nagga K, Nilsson PM, Minthon L, Nilsson ED, Palmqvist S (2017) The Montreal Cognitive Assessment: Normative data from a large Swedish population-based cohort. J Alzheimers Dis 59, 893–901.
    1. Kenny RA, Coen RF, Frewen J, Donoghue OA, Cronin H, Savva GM (2013) Normative values of cognitive and physical function in older adults: Findings from the Irish Longitudinal Study on Ageing. J Am Geriatr Soc 61(Suppl 2), S279–290.
    1. Luck T, Pabst A, Rodriguez FS, Schroeter ML, Witte V, Hinz A, Mehnert A, Engel C, Loeffler M, Thiery J, Villringer A, Riedel-Heller SG (2018) Age-, sex-, and education-specific norms for an extended CERAD Neuropsychological Assessment Battery-Results from the population-based LIFE-Adult-Study. Neuropsychology 32, 461–475.
    1. Luck T, Riedel-Heller SG, Wiese B, Stein J, Weyerer S, Werle J, Kaduszkiewicz H, Wagner M, Mösch E, Zimmermann T, Maier W, Bickel H, van den Bussche H, Jessen F, Fuchs A, Pentzek M (2009) CERAD-NP-Testbatterie: Alters-, geschlechts- und bildungs-spezifische Normen ausgewählter Subtests. Ergebnisse der German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). [CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe).]. Z Gerontol Geriatr 42, 372–384.
    1. Valliant R, Dever JA (2018) Survey weights: A Step-by-step Guide to Calculation, Stata Press.
    1. Statistics Norway (2020) National Population Projections. 12881: Population projections 1 January, by sex, age, immigration category and country background, in 15 alternatives 2020 - 2100. Available from: . Accessed August 20, 2020
    1. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A (1995) Prevalence of Alzheimer’s disease and vascular dementia: Association with education. The Rotterdam study. BMJ 310, 970–973.
    1. Engedal K, Haugen PK (1993) The prevalence of dementia in a sample of elderly Norwegians. Int J Geriatr Psychiatry 8, 565–570.
    1. Cao Q, Tan CC, Xu W, Hu H, Cao XP, Dong Q, Tan L, Yu JT (2020) The prevalence of dementia: A systematic review and meta-analysis. J Alzheimers Dis 73, 1157–1166.
    1. Prince M, Ali GC, Guerchet M, Prina AM, Albanese E, Wu YT (2016) Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther 8, 23.
    1. Helvik AS, Engedal K, Benth JS, Selbaek G (2015) Prevalence and severity of dementia in nursing home residents. Dement Geriatr Cogn Disord 40, 166–177.
    1. de Pedro-Cuesta J, Virues-Ortega J, Vega S, Seijo-Martinez M, Saz P, Rodriguez F, Rodriguez-Laso A, Rene R, de las Heras SP, Mateos R, Martinez-Martin P, Manubens JM, Mahillo-Fernandez I, Lopez-Pousa S, Lobo A, Regla JL, Gascon J, Garcia FJ, Fernandez-Martinez M, Boix R, Bermejo-Pareja F, Bergareche A, Benito-Leon J, de Arce A, del Barrio JL (2009) Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990-2008. BMC Neurol 9, 55.
    1. Goodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM (2017) Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013. Alzheimers Dement 13, 28–37.
    1. Hogan DB, Fiest KM, Roberts JI, Maxwell CJ, Dykeman J, Pringsheim T, Steeves T, Smith EE, Pearson D, Jetté N (2016) The prevalence and incidence of dementia with Lewy bodies: A systematic review. Can J Neurol Sci 43(Suppl 1), S83–95.
    1. Pessoa RMP, Bomfim AJL, Ferreira BLC, Chagas MHN (2019) Diagnostic criteria and prevalence of mild cognitive impairment in older adults living in the community: A systematic review and meta-analysis. Arch Clin Psychiatry (S&o Paulo) 46, 72–79.
    1. Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson DC, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A (2018) Practice guideline update summary: Mild cognitive impairment. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 90, 126–135.
    1. Wittenberg R, Hu B, Jagger C, Kingston A, Knapp M, Comas-Herrera A, King D, Rehill A, Banerjee S (2020) Projections of care for older people with dementia in England: 2015 to 2040. Age Ageing 49, 264–269.
    1. Brayne C, Stephan BC, Matthews FE (2011) A European perspective on population studies of dementia. Alzheimers Dement 7, 3–9.
    1. Norwegian Institute of Public Health (2016) Folkehelseinstituttet, Oslo.
    1. Lawton MP, Brody EM (1969) Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 9, 179–186.
    1. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 12, 233–239.
    1. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140, 566–572.
    1. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67, 361–370.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться